 | • レポートコード：20QY06-03976 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、マラリア薬のグローバル市場について種類別（アリールアミノアルコール化合物、抗葉酸化合物、アルテミシニン化合物）、用途別（予防、治療、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・マラリア薬市場の概要 ・世界の主要地域別マラリア薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のマラリア薬市場規模2015-2026：種類別（アリールアミノアルコール化合物、抗葉酸化合物、アルテミシニン化合物） ・世界のマラリア薬市場規模2015-2026：用途別（予防、治療、その他） ・マラリア薬の北米市場規模2015-2020 ・マラリア薬のヨーロッパ市場規模2015-2020 ・マラリア薬の中国市場規模2015-2020 ・マラリア薬の日本市場規模2015-2020 ・マラリア薬の東南アジア市場規模2015-2020 ・マラリア薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Cipla、Guilin Pharmaceutical、IPCA Laboratories、GlaxoSmithKline、Mylan Labs、Roche、Novartis、Sanofi Aventis、Ajanta Pharma） ・マラリア薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・マラリア薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Drugs for Malaria Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Drugs for Malaria market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician’s prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs for Malaria market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Drugs for Malaria industry.
Based on our recent survey, we have several different scenarios about the Drugs for Malaria YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Drugs for Malaria will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Drugs for Malaria market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Drugs for Malaria market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Drugs for Malaria market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Drugs for Malaria market. The report also includes nautical information, where it shows Drugs for Malaria market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Drugs for Malaria market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Drugs for Malaria market.
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Geographical Analysis:
Based on region, the global Drugs for Malaria market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Drugs for Malaria market are
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Segment by Type
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Segment by Application
Prevention
Treatment
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Drugs for Malaria market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Drugs for Malaria market.
• The market share of the global Drugs for Malaria market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Drugs for Malaria market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Drugs for Malaria market.
1 Drugs for Malaria Market Overview
1.1 Drugs for Malaria Product Scope
1.2 Drugs for Malaria Segment by Type
1.2.1 Global Drugs for Malaria Sales by Type (2020-2026)
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Drugs for Malaria Segment by Application
1.3.1 Global Drugs for Malaria Sales Comparison by Application (2020-2026)
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 Drugs for Malaria Market Estimates and Forecasts (2015-2026)
1.4.1 Global Drugs for Malaria Sales Growth Rate (2015-2026)
1.4.2 Global Drugs for Malaria Revenue and Growth Rate (2015-2026)
1.4.3 Global Drugs for Malaria Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Drugs for Malaria Industry Impact
1.5.1 How the Covid-19 is Affecting the Drugs for Malaria Industry
1.5.1.1 Drugs for Malaria Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Drugs for Malaria Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Drugs for Malaria Players to Combat Covid-19 Impact
2 Drugs for Malaria Estimate and Forecast by Region
2.1 Global Drugs for Malaria Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Drugs for Malaria Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Drugs for Malaria Sales Market Share by Region (2015-2020)
2.2.2 Global Drugs for Malaria Revenue Market Share by Region (2015-2020)
2.3 Global Drugs for Malaria Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Drugs for Malaria Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Drugs for Malaria Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Drugs for Malaria Estimates and Projections (2015-2026)
2.4.2 Europe Drugs for Malaria Estimates and Projections (2015-2026)
2.4.3 China Drugs for Malaria Estimates and Projections (2015-2026)
2.4.4 Japan Drugs for Malaria Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Drugs for Malaria Estimates and Projections (2015-2026)
2.4.6 India Drugs for Malaria Estimates and Projections (2015-2026)
3 Global Drugs for Malaria Competition Landscape by Players
3.1 Global Top Drugs for Malaria Players by Sales (2015-2020)
3.2 Global Top Drugs for Malaria Players by Revenue (2015-2020)
3.3 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2019)
3.4 Global Drugs for Malaria Average Price by Company (2015-2020)
3.5 Manufacturers Drugs for Malaria Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Drugs for Malaria Players (Opinion Leaders)
4 Global Drugs for Malaria Market Size by Type
4.1 Global Drugs for Malaria Historic Market Review by Type (2015-2020)
4.1.1 Global Drugs for Malaria Sales Market Share by Type (2015-2020)
4.1.2 Global Drugs for Malaria Revenue Market Share by Type (2015-2020)
4.1.3 Global Drugs for Malaria Price by Type (2014-2020)
4.2 Global Drugs for Malaria Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Drugs for Malaria Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Malaria Revenue Forecast by Type (2021-2026)
4.2.3 Global Drugs for Malaria Price Forecast by Type (2021-2026)
5 Global Drugs for Malaria Market Size by Application
5.1 Global Drugs for Malaria Historic Market Review by Application (2015-2020)
5.1.1 Global Drugs for Malaria Sales Market Share by Application (2015-2020)
5.1.2 Global Drugs for Malaria Revenue Market Share by Application (2015-2020)
5.1.3 Global Drugs for Malaria Price by Application (2015-2020)
5.2 Global Drugs for Malaria Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Drugs for Malaria Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Malaria Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Malaria Price Forecast by Application (2021-2026)
3 North America Drugs for Malaria Market Facts & Figures
3.2 North America Drugs for Malaria Sales Market Share by Company (2015-2020)
3.3 North America Drugs for Malaria Sales Market Share by Type (2015-2020)
3.4 North America Drugs for Malaria Sales Market Share by Application (2015-2020)
4 Europe Drugs for Malaria Market Facts & Figures
4.2 Europe Drugs for Malaria Sales Market Share by Company (2015-2020)
4.3 Europe Drugs for Malaria Sales Market Share by Type (2015-2020)
4.4 Europe Drugs for Malaria Sales Market Share by Application (2015-2020)
5 China Drugs for Malaria Market Facts & Figures
5.2 China Drugs for Malaria Sales Market Share by Company (2015-2020)
5.3 China Drugs for Malaria Sales Market Share by Type (2015-2020)
5.4 China Drugs for Malaria Sales Market Share by Application (2015-2020)
6 Japan Drugs for Malaria Market Facts & Figures
6.2 Japan Drugs for Malaria Sales Market Share by Company (2015-2020)
6.3 Japan Drugs for Malaria Sales Market Share by Type (2015-2020)
6.4 Japan Drugs for Malaria Sales Market Share by Application (2015-2020)
7 Southeast Asia Drugs for Malaria Market Facts & Figures
7.2 Southeast Asia Drugs for Malaria Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Drugs for Malaria Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Drugs for Malaria Sales Market Share by Application (2015-2020)
8 India Drugs for Malaria Market Facts & Figures
8.2 India Drugs for Malaria Sales Market Share by Company (2015-2020)
8.3 India Drugs for Malaria Sales Market Share by Type (2015-2020)
8.4 India Drugs for Malaria Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Drugs for Malaria Business
12.1 Cipla
12.1.1 Cipla Drugs for Malaria Corporation Information
12.1.2 Cipla Drugs for Malaria Business Overview and Total Revenue
12.1.3 Cipla Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cipla Drugs for Malaria Products Offered
12.1.5 Cipla Recent Development
12.2 Guilin Pharmaceutical
12.2.1 Guilin Pharmaceutical Drugs for Malaria Corporation Information
12.2.2 Guilin Pharmaceutical Drugs for Malaria Business Overview and Total Revenue
12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Guilin Pharmaceutical Drugs for Malaria Products Offered
12.2.5 Guilin Pharmaceutical Recent Development
12.3 IPCA Laboratories
12.3.1 IPCA Laboratories Drugs for Malaria Corporation Information
12.3.2 IPCA Laboratories Drugs for Malaria Business Overview and Total Revenue
12.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.3.4 IPCA Laboratories Drugs for Malaria Products Offered
12.3.5 IPCA Laboratories Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Drugs for Malaria Corporation Information
12.4.2 GlaxoSmithKline Drugs for Malaria Business Overview and Total Revenue
12.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Drugs for Malaria Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Mylan Labs
12.5.1 Mylan Labs Drugs for Malaria Corporation Information
12.5.2 Mylan Labs Drugs for Malaria Business Overview and Total Revenue
12.5.3 Mylan Labs Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Labs Drugs for Malaria Products Offered
12.5.5 Mylan Labs Recent Development
12.6 Roche
12.6.1 Roche Drugs for Malaria Corporation Information
12.6.2 Roche Drugs for Malaria Business Overview and Total Revenue
12.6.3 Roche Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Drugs for Malaria Products Offered
12.6.5 Roche Recent Development
12.7 Novartis
12.7.1 Novartis Drugs for Malaria Corporation Information
12.7.2 Novartis Drugs for Malaria Business Overview and Total Revenue
12.7.3 Novartis Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Drugs for Malaria Products Offered
12.7.5 Novartis Recent Development
12.8 Sanofi Aventis
12.8.1 Sanofi Aventis Drugs for Malaria Corporation Information
12.8.2 Sanofi Aventis Drugs for Malaria Business Overview and Total Revenue
12.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi Aventis Drugs for Malaria Products Offered
12.8.5 Sanofi Aventis Recent Development
12.9 Ajanta Pharma
12.9.1 Ajanta Pharma Drugs for Malaria Corporation Information
12.9.2 Ajanta Pharma Drugs for Malaria Business Overview and Total Revenue
12.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ajanta Pharma Drugs for Malaria Products Offered
12.9.5 Ajanta Pharma Recent Development
13 Drugs for Malaria Manufacturing Cost Analysis
13.1 Drugs for Malaria Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for Malaria
13.4 Drugs for Malaria Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for Malaria Distributors List
14.3 Drugs for Malaria Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Drugs for Malaria Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Drugs for Malaria Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Drugs for Malaria Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Drugs for Malaria Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Drugs for Malaria Players to Combat Covid-19 Impact
Table 8. Global Market Drugs for Malaria Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Drugs for Malaria Sales (K Units) by Region (2015-2020)
Table 10. Global Drugs for Malaria Sales Market Share by Region (2015-2020)
Table 11. Global Drugs for Malaria Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Drugs for Malaria Revenue Share by Region (2015-2020)
Table 13. Global Drugs for Malaria Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Drugs for Malaria Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Drugs for Malaria Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Drugs for Malaria Revenue Share Forecast by Region (2021-2026)
Table 17. Global Drugs for Malaria (K Units) of Key Companies (2015-2020)
Table 18. Global Drugs for Malaria Sales Share by Company (2015-2020)
Table 19. Global Drugs for Malaria Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Drugs for Malaria Revenue Share by Company (2015-2020)
Table 21. Global Drugs for Malaria by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2019)
Table 22. Global Drugs for Malaria Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Drugs for Malaria Manufacturing Sites and Area Served
Table 24. Manufacturers Drugs for Malaria Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Drugs for Malaria Players
Table 27. Global Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 28. Global Drugs for Malaria Sales Share by Type (2015-2020)
Table 29. Global Drugs for Malaria Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Drugs for Malaria Price (K Units) by Type (2015-2020)
Table 31. Global Drugs for Malaria Sales Share by Type (2021-2026)
Table 32. Global Drugs for Malaria Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Drugs for Malaria Revenue Share by Type (2021-2026)
Table 34. Global Drugs for Malaria Price (K Units) by Type (2021-2026)
Table 35. Global Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 36. Global Drugs for Malaria Sales Share by Application (2015-2020)
Table 37. Global Drugs for Malaria Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Drugs for Malaria Price (K Units) by Application (2015-2020)
Table 39. Global Drugs for Malaria Sales (K Units) by Application (2021-2026)
Table 40. Global Drugs for Malaria Sales Share by Application (2021-2026)
Table 41. Global Drugs for Malaria Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Drugs for Malaria Revenue Share by Application (2021-2026)
Table 43. Global Drugs for Malaria Price (K Units) by Application (2021-2026)
Table 44. United States Drugs for Malaria Sales (K Units) by Company (2015-2020)
Table 45. United States Drugs for Malaria Sales Market Share by Company (2015-2020)
Table 46. United States Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 47. United States Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 48. United States Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 49. United States Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 50. Europe Drugs for Malaria Sales (K Units) by Company (2015-2020)
Table 51. Europe Drugs for Malaria Sales Market Share by Company (2015-2020)
Table 52. Europe Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 53. Europe Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 54. Europe Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 55. Europe Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 56. China Drugs for Malaria Sales (K Units) by Company (2015-2020)
Table 57. China Drugs for Malaria Sales Market Share by Company (2015-2020)
Table 58. China Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 59. China Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 60. China Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 61. China Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 62. Japan Drugs for Malaria Sales (K Units) by Company (2015-2020)
Table 63. Japan Drugs for Malaria Sales Market Share by Company (2015-2020)
Table 64. Japan Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 65. Japan Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 66. Japan Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 67. Japan Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Drugs for Malaria Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Drugs for Malaria Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 74. India Drugs for Malaria Sales (K Units) by Company (2015-2020)
Table 75. India Drugs for Malaria Sales Market Share by Company (2015-2020)
Table 76. India Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 77. India Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 78. India Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 79. India Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 80. Cipla Corporation Information
Table 81. Cipla Description and Business Overview
Table 82. Cipla Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Cipla Drugs for Malaria Product
Table 84. Cipla Recent Development
Table 85. Guilin Pharmaceutical Corporation Information
Table 86. Guilin Pharmaceutical Description and Business Overview
Table 87. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Guilin Pharmaceutical Drugs for Malaria Product
Table 89. Guilin Pharmaceutical Recent Development
Table 90. IPCA Laboratories Corporation Information
Table 91. IPCA Laboratories Description and Business Overview
Table 92. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. IPCA Laboratories Drugs for Malaria Product
Table 94. IPCA Laboratories Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Drugs for Malaria Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Mylan Labs Corporation Information
Table 101. Mylan Labs Description and Business Overview
Table 102. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Mylan Labs Drugs for Malaria Product
Table 104. Mylan Labs Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Roche Drugs for Malaria Product
Table 109. Roche Recent Development
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Novartis Drugs for Malaria Product
Table 114. Novartis Recent Development
Table 115. Sanofi Aventis Corporation Information
Table 116. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Sanofi Aventis Description and Business Overview
Table 118. Sanofi Aventis Drugs for Malaria Product
Table 119. Sanofi Aventis Recent Development
Table . Ajanta Pharma Corporation Information
Table . Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Ajanta Pharma Description and Business Overview
Table . Ajanta Pharma Drugs for Malaria Product
Table . Ajanta Pharma Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Drugs for Malaria Distributors List
Table 128. Drugs for Malaria Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for Malaria Market Share by Application in 2020 & 2026
Figure 6. Prevention Examples
Figure 7. Treatment Examples
Figure 8. Other Examples
Figure 9. Global Drugs for Malaria Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Drugs for Malaria Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Drugs for Malaria Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Drugs for Malaria Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Drugs for Malaria Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Drugs for Malaria Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Drugs for Malaria Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Drugs for Malaria Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Drugs for Malaria Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Drugs for Malaria Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Drugs for Malaria Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Drugs for Malaria Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Drugs for Malaria Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Drugs for Malaria Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Drugs for Malaria Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Drugs for Malaria Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Drugs for Malaria Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Drugs for Malaria Players Market Share by Revenue in Drugs for Malaria 2015 & 2019
Figure 27. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Drugs for Malaria Revenue Share by Type (2015-2020)
Figure 29. Global Drugs for Malaria Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Drugs for Malaria Revenue Share by Application (2015-2020)
Figure 31. Global Drugs for Malaria Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Drugs for Malaria Sales Market Share by Type in 2019
Figure 33. United States Drugs for Malaria Sales Market Share by Type in 2019
Figure 34. Europe Drugs for Malaria Sales Market Share by Company in 2019
Figure 35. Europe Drugs for Malaria Sales Market Share by Type in 2019
Figure 36. Europe Drugs for Malaria Sales Market Share by Application in 2019
Figure 37. China Drugs for Malaria Sales Market Share by Company in 2019
Figure 38. China Drugs for Malaria Sales Market Share by Type in 2019
Figure 39. China Drugs for Malaria Sales Market Share by Application in 2019
Figure 40. Japan Drugs for Malaria Sales Market Share by Company in 2019
Figure 41. Japan Drugs for Malaria Sales Market Share by Type in 2019
Figure 42. Japan Drugs for Malaria Sales Market Share by Application in 2019
Figure 43. Southeast Asia Drugs for Malaria Sales Market Share by Company in 2019
Figure 44. Southeast Asia Drugs for Malaria Sales Market Share by Type in 2019
Figure 45. Southeast Asia Drugs for Malaria Sales Market Share by Application in 2019
Figure 46. India Drugs for Malaria Sales Market Share by Company in 2019
Figure 47. India Drugs for Malaria Sales Market Share by Type in 2019
Figure 48. India Drugs for Malaria Sales Market Share by Application in 2019
Figure 49. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. IPCA Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Mylan Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ajanta Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Drugs for Malaria
Figure 60. Manufacturing Process Analysis of Drugs for Malaria
Figure 61. Drugs for Malaria Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
マラリアワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Malaria Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 23 million by 2025, from USD 14 million in 2019. The Malaria Vaccines market re…- マラリア迅速診断テスト（RDT）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Malaria rapid diagnostic tests (RDTs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Malaria…
- エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…